Evidence map›Paper›PMID 25352216›Full record

ArticleChemical biology & drug design2015

A Molecular Dynamics Investigation of Mycobacterium tuberculosis Prenyl Synthases: Conformational Flexibility and Implications for Computer-aided Drug Discovery.

Meekyum Olivia Kim, Xinxin Feng, Ferran Feixas, Wei Zhu, Steffen Lindert, Shannon Bogue, William Sinko, César de Oliveira, Guodong Rao, Eric Oldfield and 1 more

Open access · greenAbstract read
In one paragraph

Article in Chemical biology & drug design, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Antiinfectives targeting enzymes and the proton motive force.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Meekyum Olivia KimDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 92093, USA.
Xinxin FengDepartment of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
Ferran FeixasDepartment of Pharmacology, University of California San Diego, La Jolla, CA, 92093, USA.
Wei ZhuDepartment of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
Steffen LindertDepartment of Pharmacology, University of California San Diego, La Jolla, CA, 92093, USA.
Shannon BogueDepartment of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
William SinkoDepartment of Pharmacology, University of California San Diego, La Jolla, CA, 92093, USA.
César de OliveiraDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 92093, USA.
Guodong RaoDepartment of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
Eric OldfieldDepartment of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
James Andrew McCammonDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 92093, USA.
University of California, San Diego · USUniversity of Illinois Urbana-Champaign · US

Funding

THEORY OF BIOMOLECULAR DIFFUSIONR01GM031749 · NIGMS · UNIVERSITY OF HOUSTON · PI HUBER, GARY ALEXANDER, MCCAMMON, JAMES ANDREW · 1985 to 2022
$7.8M
Structure, Function and Inhibition of [4Fe-4S] ProteinsR01GM065307 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI OLDFIELD, ERIC · 2002 to 2017
$5.4M
Next generation bisphosphonates for chemo- and immuno-therapyR01CA158191 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI OLDFIELD, ERIC · 2011 to 2015
$1.6M
Howard Hughes Medical InstituteNCI NIH HHS CA158191NCI NIH HHS R01 CA158191NIGMS NIH HHS GM031749NIGMS NIH HHS GM065307NIGMS NIH HHS R01 GM031749NIGMS NIH HHS R01 GM065307
6 · The paper itself

Abstract

With the rise in antibiotic resistance, there is interest in discovering new drugs active against new targets. Here, we investigate the dynamic structures of three isoprenoid synthases from Mycobacterium tuberculosis using molecular dynamics (MD) methods with a view to discovering new drug leads. Two of the enzymes, cis-farnesyl diphosphate synthase (cis-FPPS) and cis-decaprenyl diphosphate synthase (cis-DPPS), are involved in bacterial cell wall biosynthesis, while the third, tuberculosinyl adenosine synthase (Rv3378c), is involved in virulence factor formation. The MD results for these three enzymes were then compared with previous results on undecaprenyl diphosphate synthase (UPPS) by means of active site volume fluctuation and principal component analyses. In addition, an analysis of the binding of prenyl diphosphates to cis-FPPS, cis-DPPS, and UPPS utilizing the new MD results is reported. We also screened libraries of inhibitors against cis-DPPS, finding ~1 μm inhibitors, and used the receiver operating characteristic-area under the curve (ROC-AUC) method to test the predictive power of X-ray and MD-derived cis-DPPS receptors. We found that one compound with potent M. tuberculosis cell growth inhibition activity was an IC(50) ~0.5- to 20-μm inhibitor (depending on substrate) of cis-DPPS, a ~660-nm inhibitor of Rv3378c as well as a 4.8-μm inhibitor of cis-FPPS, opening up the possibility of multitarget inhibition involving both cell wall biosynthesis and virulence factor formation.

Indexed as

Alkyl and Aryl TransferasesAntitubercular AgentsComputer-Aided DesignCrystallography, X-RayDrug DesignEnzyme InhibitorsGeranyltranstransferaseHumansMolecular Docking SimulationMolecular Dynamics SimulationMycobacterium tuberculosisTuberculosisAlkyl and Aryl TransferasesAntitubercular Agentsdecaprenyl pyrophosphate synthetaseEnzyme InhibitorsGeranyltranstransferaseundecaprenyl pyrophosphate synthetasedecaprenyl diphosphate synthasedockingdrug discoveryenzymatic mechanismfarnesyl diphosphate synthasemolecular dynamicsmolecular modelingprenyl synthasetuberculosinyl adenosine synthasetuberculosis

Identifiers

PMID25352216
PMCPMC4412765
OpenAlexW2106228495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.